<DOC>
	<DOCNO>NCT00110747</DOCNO>
	<brief_summary>Lasers use non-ablative resurface facial rhytides , atrophic scar , variety epidermal dermal lesion . Pain associate non-ablative laser treatment describe moderate severe . For reason , local anesthesia commonly use eliminate minimize pain . S-Caine™ Peel ( lidocaine 7 % tetracaine 7 % cream ) eutectic formulation lidocaine tetracaine . The purpose study evaluate S-Caine Peel effective provide topical local dermal anesthesia non-ablative facial laser resurface adult .</brief_summary>
	<brief_title>S-Caine™ Peel ( Skin Numbing Cream ) Treat Pain During Non-Ablative Facial Laser Resurfacing Adults</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , placebo-controlled , paired study evaluate effectiveness S-Caine Peel provide local dermal anesthesia non-ablative facial laser resurfacing . Patients receive concurrent application S Caine Peel placebo 30 minute ( ±2 minute ) . Patients present study site non-ablative facial laser resurface meet study entry criterion invite participate study . At screen visit , study , include potential risk benefit , clearly explain patient , write informed consent obtain . A medical history obtain include skin type , demographic data , prior current medical disorder , use concomitant medication . A brief physical examination perform include take basic vital sign examine skin study drug application site . If applicable , urine pregnancy test perform . The screening visit could occur day procedure visit . At procedure visit , patient randomize receive 30-minute ( ±2 minute ) application S Caine Peel either right leave treatment area receive concurrent 30-minute ( ±2 minute ) application placebo alternate treatment area . The point reference always patient 's right left . S-Caine Peel placebo dispense cover treatment area uniform thickness approximately 1 mm . Study drug apply right treatment area first , concurrently leave treatment area . Similarly , study drug remove first right treatment area leave treatment area . Following removal study drug , investigator physician subinvestigator evaluate study drug application site erythema , edema , blanch skin reaction . The right treatment area evaluate first , follow left treatment area . After skin evaluation , laser procedure perform right treatment area , follow patient investigator efficacy evaluation right treatment area . The laser procedure perform left treatment area , follow patient investigator efficacy evaluation leave treatment area .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Patient 18 year age old Patient elect undergo nonablative facial laser resurface procedure Patient pregnant breastfeeding Patient participate clinical trial unapproved drug within previous 30 day Patient participate previous clinical trial involve SCaine Peel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>